Nanologica AB (publ) has completed a private placement of shares through an accelerated bookbuilding procedure. The transaction was directed to institutional and qualified private investors and through the share issue, which was oversubscribed, Nanologica will receive approximately SEK 57 million before costs related to the transaction.
Swedbank Robur Medica subscribes for 2.5 million shares, corresponding to SEK 25.75 million in the share issue. The remaining circa 3 million shares have been subscribed for by a number of qualified private and institutional investors, including Nordic Cross.
The subscription price has been set at SEK 10.30 by an accelerated bookbuilding procedure, corresponding to a discount of appr. 8.8 percent compared to the closing price for Nanologica's share on Spotlight Stock Market on May 25, 2020. The subscription price is in line with the volume weighted average price during the ten last trading days.
Lindahl law firm acted as legal adviser to Nanologica in connection with the transaction. Lindahl's team consisted of Mårten Steen and Emira Peterson. Erik Penser Bank AB acted as financial advisor in connection with the transaction.